マンモグラフィーの世界市場2021-2026:成長・動向・新型コロナの影響・市場予測

◆英語タイトル:Mammography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)
◆商品コード:MOR21MR081
◆発行会社(リサーチ会社):Mordor Intelligence
◆発行日:2021年2月
◆ページ数:119
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2-3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名利用)USD4,250 ⇒換算¥484,500見積依頼/購入/質問フォーム
Team User(5名利用)USD4,750 ⇒換算¥541,500見積依頼/購入/質問フォーム
Corporate License(法人利用)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMordor Intelligence社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Mordor Intelligence社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査資料では、世界のマンモグラフィー市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別(デジタルシステム、アナログシステム、乳房トモシンセシス、その他)分析、エンドユーザー別(病院、専門クリニック、診断センター)分析、地域別分析、競争状況、市場機会/将来の見通しなどを掲載しています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・市場動向
・世界のマンモグラフィー市場規模:製品種類別(デジタルシステム、アナログシステム、乳房トモシンセシス、その他)
・世界のマンモグラフィー市場規模:エンドユーザー別 (病院、専門クリニック、診断センター)
・世界のマンモグラフィー市場規模:地域別
・競争状況
・市場機会/将来の見通し
【レポートの概要】

The major factors responsible for the growth of the mammography market include the growing prevalence of breast cancer, technological advancements in the field of breast imaging, and investment from various organizations in breast cancer screening campaigns.

- According to the Centers for Disease Control and Prevention (CDC) reports, breast cancer is one of the most common cancers among women, irrespective of race or ethnicity. It is also the third most common cause of death from cancer among American Indian/Alaska Native women.
- According to the estimates of the Globocan, there were 2,088,849 new cases of breast cancer in 2018. Furthermore, as the global population is aging, a large number of women are expected to move into the 60 and above age category. Women aged 60 years and above account for almost 78% of all breast cancer-related deaths. High-incidence and mortality rates for breast cancer in this age group represent a huge unmet need for breast cancer diagnostics. As the number of incidents and mortality cases is increasing, the demand for mammography is also expected to increase. This remains a major driver for the mammography market and is expected to boost the market during the forecast period.

Key Market Trends

The Digital Mammography Segment is Expected to Account for the Largest Market Share During the Forecast Period

Digital mammography is a specialized and advanced form of mammography that uses digital receptors and computers instead of X-ray films to examine breast tissue for the presence of tumors. So far, conventional screen-film mammography (SFM) with high-spatial resolution has been the preferred choice for screening programs in most countries. However, with the advent of digital mammography, an increasing number of countries are experiencing shifts toward these newer systems, due to their superior depiction of low-contrast objects, wider dynamic change, and improved diagnostic quality of images, especially when examining denser breasts. They also come with an added advantage of soft-copy image displays and soft-copy reading, which can be easily transferred. Mammography screening in various countries, such as in the United Kingdom, is now digital, which offers greater precision, better quality, and higher efficiency. Thus, digital mammography is becoming the preferred choice of screening, even though the cost of the new technology is six times higher than the conventional systems. Radiation exposure is significantly lower as compared to analog systems. Full-field digital mammography is the most common form of digital mammography employed. It offers the potential for significant advances in breast cancer diagnosis, including lower radiation dosages, reduced breast compression pressure, and improved detection. All these advantages aid in the growth of the market over the forecast period.

North America Accounts for the Largest Share in the Global Market

North America is found to hold a major share for the mammography market, and it is expected to show a similar trend over the forecast period, without significant fluctuations. The rising prevalence of breast cancer and the presence of better healthcare infrastructure in the region are expected to drive the overall growth of the market over the forecast period.

As per the estimates of Breastcancer.org, an estimated 268,600 new cases of invasive breast cancer were diagnosed in women in the United States in 2019. Furthermore, there is a rise in funding activity for research in breast cancer. For instance, according to the NCI budget factbook, breast cancer received funding of USD 545.1 million in 2017. In the United States, the National Breast Cancer Foundation (NBCF) is the organization that provides breast cancer education and free mammograms to women in need. This organization conducts various programs, such as National Mammography Program, Beyond The Shock, Patient Navigation, and Breast Health Awareness. Thus, owing to the rising prevalence of breast cancer and awareness among the population, the market is expected to experience growth over the forecast period.

Competitive Landscape

The mammography market is a consolidated one, owing to the presence of a few major players in the market. The major market players are focusing on technological advancements and reducing the side effects of the procedures. Some of the major players in the market are Analogic Corporation, Canon Medical Systems Corporation, Fujifilm Corporation, GE Healthcare, Hologic Inc., Koninklijke Philips NV, and Siemens Healthineers.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

【レポートの目次】

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of Breast Cancer
4.2.2 Technological Advancements in the Field of Breast Imaging
4.2.3 Investment from Various Organizations in Breast Cancer Screening Campaigns
4.3 Market Restraints
4.3.1 Risk of Adverse Effects from Radiation Exposure
4.3.2 Reduction in Reimbursement
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Digital Systems
5.1.2 Analog Systems
5.1.3 Breast Tomosynthesis
5.1.4 Other Product Types
5.2 By End Users
5.2.1 Hospitals
5.2.2 Specialty Clinics
5.2.3 Diagnostic Centers
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Fujifilm Holdings Corporation
6.1.2 GE Healthcare
6.1.3 Hologic Inc.
6.1.4 GENERAL MEDICAL MERATE SpA
6.1.5 Koninklijke Philips NV
6.1.6 Metaltronica SpA
6.1.7 Konica Minolta Inc.
6.1.8 Planmed Oy
6.1.9 Siemens Healthineers
6.1.10 Carestream Health

7 MARKET OPPORTUNITIES AND FUTURE TRENDS



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[マンモグラフィーの世界市場2021-2026:成長・動向・新型コロナの影響・市場予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆